Getting Smart about Diabetes

Article

Hear Dr. Robertson speak about the need to collaborate on discoveries for diabetes treatments in order to improve future global health.

Diabetes & Obesity Series


Getting Smart about Diabetes

Subscribe to RSS feed of this series



R. Paul Robertson, MD, President and Scientific Director Pacific Northwest Diabetes Research Institute President-Elect, Science and Medicine, American Diabetes Association



In this Podcast Dr. Robertson speaks about the need to collaborate on discoveries for diabetes treatments in order to improve future global health.

Others in the Series



Diabetes Resources

Associations and Societies


Clinical Trials

Obesity Resources

Articles, Multimedia


Associations and Societies

Clinical Trials

Recent Videos
Related Content
Credit: bizoo_n | stock.adobe.com

COVID-19 Five Years Later: The Impact on Drug Discovery

Phil Mounteney
March 20th 2025
Article

COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive clinical trial design.

© putilov_denis - © putilov_denis - stock.adobe.com.

Leveraging Technology for Efficient Trial Design

Sowmyanarayan Srinivasan, Tanvi Vedhera, Garima Prashad, and Vishakha Sharma
March 7th 2025
Article

Teams must work together with technology solutions and optimize integration to unlock their full potential.

© Egor - © Egor - stock.adobe.com

Three Ways AI is Revolutionizing Clinical Development

Gen Li, PhD, MBA
February 26th 2025
Article

How targeted AI can improve the performance of clinical trials.

SCOPE Summit 2025: Steve Rosenberg on Setting the Tone for the Patient and Site Journey

SCOPE Summit 2025: Steve Rosenberg on Setting the Tone for the Patient and Site Journey

Don Tracy, Associate Editor
February 5th 2025
Article

Conference breakout session explores strategies for trial sites to strengthen patient relationships.

Credit: Gorodenkoff | stock.adobe.com

The Value of Clinical Trial Liaisons in the Drug Development Lifecycle

Daniella Tinoco, PhD and Christine Moore, PhD
February 4th 2025
Article

Clinical trial liaisons rather serve as experts in their therapeutic areas and as clinical trial specialists to provide a suite of strategic advantages to benefit a study.

Credit: photon_photo | stock.adobe.com

Study Finds Many Randomized Clinical Trials Have Poorly Justified Exclusion Criteria

Davy James
January 21st 2025
Article

Investigators find that most exclusion criteria in critical care randomized clinical trials are justifiable, but 60% include at least one poorly justified exclusion, most commonly affecting pregnant or lactating individuals.

© 2025 MJH Life Sciences

All rights reserved.